PRO: An observational study to validate PRO in patients with psoriasis
Research type
Research Study
Full title
An observational prospective multi clinic study to validate the PSOriasis specific Patient Reported Outcome questionnaire PPQ in patients with mild to severe psoriasis vulgaris currently using medication in United Kingdom
IRAS ID
277832
Contact name
Anthony Bewley
Contact email
Sponsor organisation
LEO Pharma A/S
Clinicaltrials.gov Identifier
NA, NA
Duration of Study in the UK
0 years, 6 months, 1 days
Research summary
This is a multi-centre, observational, prospective study to validate the Patient Profile Questionnaire (PPQ) in patients suffering from psoriasis. The study will be conducted in the United Kingdom (UK).
The study is based on prospective collection of data from patients' medical records and from questionnaires completed by patients. Patients will be asked to complete a set questionnaires after confirming that they are eligible and they have signed the consent and again via an online survey after 7 to max 21 days. There will be no changes to patient management for the purposes of any part of the study and no additional tests, investigations or visits will be required.
The population for this study is adult patients diagnosed with mild to severe psoriasis who are currently using medication as part of their standard clinical care in the UK. It is expected to recruit 150 patients in total.
REC name
North West - Greater Manchester South Research Ethics Committee
REC reference
20/NW/0108
Date of REC Opinion
3 Mar 2020
REC opinion
Favourable Opinion